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The  problem  of  standardizing  antisera  intended  for  therapeutic 
purposes is an ever important one.  In the last analysis, of course, the 
value of a  serum must be decided by its therapeutic efficiency, but 
unless the relationship of the latter to some of the more conveniently 
measurable immunity reactions is  determined, no  criterion  can  be 
established whereby the probable therapeutic potency of an otherwise 
unknown serum may be estimated.  The discovery of such a relation- 
ship depends primarily upon elucidation of the antigenic structure of 
the infective agent in question.  For example, with Type I antiimeu- 
mococcal sera, it has been possible to demonstrate a close correlation 
between various of the immunity reactions, in which the antibody to 
the  type-specific polysaccharide is  the factor  of  prime  importance 
(1, 2).  The situation has been less favorable in the case of the men- 
ingococcus, and as yet no satisfactory solution to the problem has been 
published. 
Standardization of Type I  Sera 
Wadsworth  (3)  and Murray  (4)  have discussed the results which 
have been obtained in the past by applying various of the immunity 
reactions in attempts to establish a  reliable measure of the potency 
of antimeningococcal sera.  The agglutination reaction has been the 
most widely used and reliable method, and although the agglutinin 
* Part of this work was completed by one of us while working in the laboratories 
of the Department of Medicine  of the College of Physicians and Surgeons.  The 
authors wish to thank Dr. Michael Heidelberger for the facilities  placed at their 
disposal. 
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titre is not  necessarily an index of therapeutic potency,  there  is evi- 
dence that sera of high titre possess therapeutic efficiency (3). 
The precipitin reaction has not proved satisfactory in the past chiefly 
because the precipitinogen commonly used  (a crude extract of menin- 
gococci) is not readily standardized  and reproduced.  Zozaya (5)  has 
used what was probably the group-specific polysaccharide, or C  sub- 
stance, of the meningococcus as the precipitating  antigen.  The isola- 
tion from the Type I  meningococcus of a  highly purified, type-specific 
substance  (6,  7)  (to  be  referred  to  hereafter  as  S I)  suggested  the 
possibility of accurate measurement of the precipitin content of Type 
I  antimeningococcal  sera  by  the  quantitative  method  developed  by 
Heidelberger  and  Kendall  (8).  This has been  done  and  in  addition 
the method has been applied in following the fractionation and purifica- 
tion of such sera. 
The sera used were prepared by immunizing a  horse with vaccines prepared 
from recently isolated strains of Type I  meningococcus  according to the method 
already described  (9).  The S I  samples used were preparations 8 and  18 pre- 
viously described (7).  These were found to be identical with respect to precipitat- 
ing potency with horse sera. 
The  technique  for the  determination  of nitrogen  in  the  specific precipitates 
produced by the reaction between the sera and S I  (to be referred to hereafter as 
antibody nitrogen  1) followed closely that described  by Heidelberger and Kendall. 
1 or 2 cc. of serum or an equivalent amount of antibody solution (not more than 
0.4  mg. antibody nitrogen)  have been used.  Since  all of these contained pre- 
servative, sterile precautions were not observed.  The sample was measured by a 
calibrated pipette into a  Wassermann  tube and 0.025 mg. of S I in solution was 
added  for each  cc.  of  serum.  Duplicate  tubes  and  salt  control  tubes  were 
set up in all cases.  The volume was adjusted to 4 cc. with saline and the tubes 
were dosed with rubber caps.  The contents were then mixed thoroughly and the 
tubes were allowed to stand for 1 or 2 hours at room temperature (20-25°C.). 
This procedure gave results identical with those obtained when the tubes were 
subjected to the customary 2 hour period of incubation at 37°C.  It is realized 
that this method probably did not result in as complete precipitation of antibody 
as would have been obtained if all operations had been carried out at 0°C.  (8), 
but this fact was not important for the purposes at hand.  After the preliminary 
period of standing, the tubes were placed in the refrigerator and left for 18 to 24 
1 Since S I probably contains nitrogen as a constituent of its molecule, part of 
the antibody nitrogen may be attributable to  the S I  contained in  the specific 
precipitate.  However, the total amount of S I  nitrogen added in one of these 
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hours.  They were then centrifuged in the cold.  The specific precipitates  formed 
compact discs which could not be readily broken up.  For the first washing, the 
precipitate  was suspended in 3 to 4 cc. of chilled saline,  left for 1 hour at 0°C., 
and centrifuged off as before.  For the second washing, it was found best to allow 
the precipitate  to stand in contact with 3 to 4 cc. of saline at 0°C. for 16 to 24 
hours with occasional shaking.  In the first determinations  a third washing was 
made, but this was found to be superfluous.  Finally, the precipitate  was centri- 
fuged off in the cold.  It was then dissolved in a little distilled water with the aid 
of a few drops of N/1 sodium hydroxide.  The solution was rinsed into a 125 cc. 
Kjeldahl flask and the nitrogen determination was carried  out according  to a 
slight modification of the Pregl micro Kjeldahl method. 
Heidelberger  and Kendall  (8),  studying the  reaction  between  the 
Type III pneumococcus polysaccharide and its antibody, found that 
when  increasing  amounts  of  polysaccharide  were  added  to  a  fixed 
amount of antibody, the quantity of precipitate formed increased to a 
maximum and  then  remained  constant over a  wide  range  until  the 
inhibition  zone  was  reached.  A  similar  relationship  exists  for  the 
present  system.  It  was  found,  with  samples  of  serum  containing 
between 0.15  and 0.20 mg. of specifically precipitable nitrogen, that 
identical results were obtained over the range 0.02 to 0.10 rag.  of  S  I 
added.  After  removal  of  the  specific precipitates,  portions  of  the 
supernatant fluids were tested in each case (a) with an equal volume 
of antiserum, and (b) with an equal volume of a  1:50,000  solution of 
S I  in saline.  The  (a)  tests all showed strong reactions, whereas the 
(b)  tests were uniformly negative, thus showing that S I  was present 
in excess in all cases.  Less than 0.02 mg. of S I  added could not be 
relied upon to give maximum precipitation, whereas 0.3 mg. produced 
inhibition  or  prozone  phenomenon.  Since  it  was  desired  to  char- 
acterize  the  sera  by  determining  under  standard  conditions  the 
maximum  amount  of  specifically precipitable  nitrogen  which  they 
contained, the procedure finally adopted was to add 0.025 mg. of S I 
(0.5  cc.  of a  1:20,000  solution in saline)  per cc.  of serum  (antibody 
nitrogen  content,  0.1  to  0.2  mg.  per  cc.).  These  proportions  were 
maintained throughout and were found sufficient to provide a definite 
excess of S I  but at the same  time to be remote from the inhibition 
zone.  The  supernatants  from  all  determinations  were,  of  course, 
tested qualitatively for the presence of excess S I  and antibody. 
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antibody nitrogen.  The results are shown in Table I.  Each figure 
represents the average of at least two determinations which checked to 
within less than 0.01  rag.  The results  are  therefore believed  to  be 
accurate to within ±0.005 mg. 
It will be seen that the sera used (representing successive bleedings 
from the same horse)  contained between  1  and  2  per cent of their 
nitrogen in the form of antibody (0.1 to 0.2 rag. antibody nitrogen per 
cc.).  This is rather a low figure in comparison with the results found, 
for example, with some antipneumococcal horse sera, where the figure 
may be at least ten times as great.  Thus Felton  (2), in a  study of 
TABLE  I 
Analysis of Type I  Antimeningococcal  Horse Sera 
Sernm NO. 
1 +  2 pooled 
Same after 6 mos. 
3 
Same after 6 mos. 
4 
Same after 6 mos. 
5 
Same after 6 mos. 
6 
7 
8 
Antibody N 
p~ cc. 
mg. 
0.185 
0.150 
0.135 
0.118 
0.178 
0.174 
0.177 
0.181 
0.105 
0.121 
0.109 
Antibody N[ 
['otal N  Total N  [  per cc. 
I 
rag.  i  ~erccnt  I 
10.78  1.25 
13.46  1.32 
10.80  1.63 
12.08  1.00 
Remarks 
Preserved with tricresol 
"  "  merthiolate 
thirty-nine sera from thirty-seven horses immunized against Types I 
and II pneumococcus, found that the content of antibody to the Type 
I specific substance varied from 0.22 to 2.36 rag. nitrogen per cc.  The 
low figures of the present series are probably due to the antibody re- 
sponse characteristic of the particular horse used for  immunization 
against  Type I meningococcus, for,  in  the  case  of  one  polyvalent 
antimeningococcal horse serum tested, an antibody nitrogen content 
(Type I) of 0.97  rng. per cc. was observed, a  figure which compares 
more favorably with those quoted above from Felton.  It was thought 
that the low results might be due to a loss of precipitinogenic potency 
of the S I solution on prolonged storage in the refrigerator.  Such was 
not the case, for a given solution of S I precipitated identical amounts HENRY  W.  SCHERP  AND  GEOYl~REY  RAKE  551 
of antibody on two occasions, 6 months apart (sera 4 and 5).  It was 
also  possible  that  the  S I  had  lost  part  of its  precipitating  power 
because of the process used in purifying it  (7).  Thus,  it has been 
shown (10) that fragments prepared by partial hydrolysis of Type III 
pneumococcus polysaccharide may still  exhibit precipitating  action 
when tested with homologous horse antiserum but not with rabbit 
antiserum.  However, even at  dilutions as high as  1:2,000,000,  S I 
precipitates homologous rabbit antiserum (7) and there is no evidence 
that it has been isolated in a partially hydrolyzed condition, for it gives 
TABLE  II 
Titres of Type I Antimeningococcal Horse Sera against Various 
Meningococcus Antigens 
Date 
1933 
Apr.  1 
Dec.  1 
1934 
Feb.  1 
May 15 
Oct.  1 
Oct. 15 
1935 
Jan.  1 
Set  N'o. 
I  2 
Anfi-SI 
1:8,000,000 
1:8,000,000 
1:8,000,000 
1:8,000,000 
1:8,000,000 
1:8,000,000 
1:8,000,000 
Anti-C - 
1:100 
1:1,000 
1:10,000 
1:10,000 
1:10,000 
1:10,000 
1:10,000  1:100 
Anti-P  Agglutinati¢  Type I 
i  i 
0  1:800 
1:1,000  1:800 
1:100  1:1,500 
1:1,000  1:1,500 
1:100  1:3,200 
1:100  1:3,200 
1:6,400 
Agglutination 
Type II 
1:20 
1:100 
1:100 
1:100 
1:100 
1:100 
1:100 
Agglutinin titres represent dilutions of serum; the other titres represent di- 
lutions of antigens. 
no test for reducing sugars until it has been subjected to acid hydrol- 
ysis. 
It is of interest in connection with the problem of preserving sera 
that the antibody content of sera in the presence of some preservatives 
may remain quantitatively constant over a protracted period of time. 
Thus,  sera  4  and  5,  which  contained  0.01  per  cent  merthiolate,  2 
showed no  change in  antibody  content  after 6  months'  storage  at 
0-4°C.  On  the  other hand,  in  a  similar  experiment,  sera  1  -I-  2 
pooled, and 3, which contained 0.3 per cent tricresol, showed respec- 
tively a loss of 19 per cent and 13 per cent within the same period. 
2  Supplied through the kindness of Eli Lilly and Co., Indianapolis. 552  MENINGOCOCCUS  INFECTION.  IX 
In Table II are shown, for comparative purposes, the titres observed 
when  the  sera  were  tested  against  S I,  against  the  group-specific 
polysaccharide,  C,  against  the  group-specific  protein,  P,  and  (for 
agglutination)  against  Types  I  and  II  meningococcus.  3  The  most 
salient  feature of these data is the relatively extremely high  anti-S I 
titre,  1:8,000,000.  The  anti-C  and  anti-P  titres  remained  low 
throughout  (maximum  =  10-* and 10  -3 respectively) as did the Type 
II  agglutination  titre,  which was never higher  than  1:100.  On  the 
other hand, the Type I agglutination titre was 1 : 800 at the first bleed- 
ing,  and rose continuously to  1:6,400.  This rise was not parallelled 
by an increase in the anti-S I  content of the sera, and for the present 
such lack of correlation must remain unexplained. 
Purification  and Concentration of Serum 
The accumulated evidence of past work indicates that the antibody 
in antimeningococcal horse serum is associated with the water-insol- 
uble  globulin  fraction  in  a  relationship  similar  to  that  found  with 
antipneumococcal horse serum  (11).  Murdick and  Cohen  (12) have 
recently  reviewed  the  subject  and  they  confirm  this  fact.  By  a 
process of dialysis and isoelectric precipitation they were able to precip- 
itate nearly all of the antibody  (as measured by the agglutinin  titre 
and neutralizing  potency in  the phenomenon  of local skin  reactivity 
(13)). 
The method to be presented differs from that of the above authors 
chiefly in  the  fact  that  the  water-insoluble  globulin  fraction  of  the 
horse serum has been precipitated by the use of carbon dioxide.  The 
latter procedure is not a new one.  Avery (14) has used it in fraction- 
ating antipneumococcal horse serum.  He found thatif aType II serum, 
diluted tenfold with distilled water, was saturated with carbon dioxide, 
somewhat more  than  one-half of the protective power was found in 
the precipitate. 
In an  experiment along the lines of that of Avery, a  sample of serum 3 was 
diluted fivefold with distilled water.  Carbon dioxide was bubbled slowly through 
the  solution at  room temperature  until  it  was obvious that  a  precipitate had 
formed.  The solution was then left for 1 hour in the refrigerator.  The precipitate 
3  Agglutinations were carried out for 2 hours at 37°C. and  overnight in the 
ice box. HENRY  W.  SCHERP  AND  GEOFFREY  RAKE  553 
was  collected  by centrifuging.  It was dissolved  in  a  volume of 0.85  per cent 
sodium chloride solution equal to that of the original serum.  To the dear, super- 
natant fluid was added sufficient solid sodium chloride  to make a final concentra- 
tion of 0.85 per cent.  Both solutions were neutralized with N/1 sodium hydroxide 
and then tested qualitatively with 1:10,000  and 1:50,000  dilutions of S I. 
The  two  solutions  thus  prepared  reacted  strongly,  and  it  was 
estimated that at least one-half of the antibody present had not been 
precipitated. 
It was next found that if the serum was subjected to dialysis before 
being  diluted,  treatment  with  carbon  dioxide  precipitated  all  of  the 
antibody.  The results of tests on the fractions obtained in a  typical 
experiment using a  sample of serum 3 are shown in Table III. 
TABLE  III 
Fractionation of Type I  Antimeningococcal Horse Serum by Dialysis  and 
Precipitation with Carbon Dioxide 
Dialysis precipitate  COs precipitate  COs  Control, 
(fraction  A)  (fraction B)  supernatant  original serum 
1:10,000 S I  -[-'{- pd  q--I-+ pd  --  +-I-q- pd 
1:50,000 S I  -b p  -b+ pd  --  +++  pd 
Readings made after 2 hours at 37°C. 
pd indicates formation of disc-like precipitate easily broken up by agitation. 
p indicates formation of finely divided precipitate. 
On dialysis,  a  precipitate separated out from the serum.  This was collected 
separately and  labeled  fraction  A.  The  bulk of  the  serum  was  then  diluted 
fivefold  with  distilled  water  and  treated  with  carbon  dioxide  as  above.  The 
resultant precipitate was labeled fraction B.  Each precipitate was dissolved  in a 
volume of 0.85  per  cent  sodium  chloride  equal  to  that  of  the  original  serum. 
Sodium chloride  was  added  to  the  supernatant  fluid  from the  carbon  dioxide 
precipitation to make a  final concentration of 0.85 per cent.  All solutions were 
neutralized  with  N/1  sodium  hydroxide  and  centrifuged  before  being  tested 
with S I.. 
It will be seen that fraction A  contained a  considerable  amount of 
antibody  and  that  fraction  B  reacted  almost  as  strongly  as  did  the 
original  serum.  The most important  fact was  that  the  supernatant 
fluid  after  the  removal of fraction  B  failed  to  react,  indicating  that 
the  antibody  had  been  precipitated  quantitatively.  This  was  sub- ~54  MENINGOCOCCUS  INFECTION.  IX 
stantiated  in  a  similar  experiment  in  which  100  cc.  of  serum  3  was 
fractionated.  This  represented  13.5  mg.  of  antibody  nitrogen. 
Fraction A was found to contain 4.58 rag. (34 per cent) of the antibody 
nitrogen,  whereas  fraction B  contained  8.55  mg.  (63 per  cent).  The 
total recovery was therefore 97 per cent. 
On the basis of these findings, the following method has been evolved 
for  the  purification  and  concentration  of  Type  I  antimeningococcal 
horse serum. 
Portions of 100  to 400 cc. of serum have been used, both with and without 
preservative (0.3 per cent tricresol or 0.01 per cent merthiolate).  The serum was 
placed in a bag made of either cellophane or collodion and dialyzed against cold 
running  tap  water  for 24 hours.  Serum  which  contained no  preservative  was 
protected  against  contamination  by  the  use  of  toluene  or  chloroform.  The 
precipitate which separated out as a result of dialysis was collected by centrifuging 
and  treated  as  below.  The  supernatant  was  set  aside  for  the  carbon dioxide 
precipitation. 
The dialysis precipitate  was taken  up  in a  volume of 0.85  per  cent sodium 
chloride  4 equal to  1/15  to  1/30 the volume of the original serum.  The volume 
chosen  depended  upon  the  extent  to  which  it  was  desired  to  concentrate  the 
antibody.  The former quantity  ensured  easier  manipulation  and  gave a  final 
product having a volume 1/3 to 1/4 that of the original serum.  The solution of 
the dialysis precipitate  was usually very cloudy and could not be satisfactorily 
clarified  by  centrifuging  or  increasing  the  salt  content  of  the  solution.  This 
effect was especially pronounced in those cases where tricresol had been used as 
preservative.  It was found that  the addition  of 0.5  to  2  volumes of distilled 
water to the solution would cause the formation of a precipitate consisting mostly 
of inactive material.  When this precipitate was centrifuged off, the supernatant 
was quite  clear and entirely satisfactory even for precipitin  ring tests,  where a 
slight  cloudiness in the serum makes reading difficult.  The exact proportion of 
distilled water necessary to throw out this inactive material from solution varied 
from one preparation  to another and depended particularly on the protein con- 
centration.  Thus, the smaller the volume of saline used for dissolving the dialysis 
precipitate,  the  larger  had  to  be  the  proportion  of distilled  water  added.  In 
general, not less  than  0.5  volume nor more than 2 volumes was required.  Care 
must be exercised in carrying out this step, for the use of an excess of distilled water 
caused precipitation and denaturation of the antibody, which then proved to be 
insoluble in saline and had to be discarded. 
The bulk of the dialyzed serum was diluted to five times the volume of the 
original serum with distilled water saturated with chloroform to prevent bacterial 
4 All solutions contained 0.01  per cent merthiolate,  except the distilled water 
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contamination.  A slow current of carbon dioxide was passed through the solution 
until  aggregates of precipitate formed which  were  readily visible.  The  carbon 
dioxide treatment  was  continued for  15  minutes  to  ensure  the  presence of an 
excess of the gas.  The precipitate could be centrifuged off immediately without 
serious loss of antibody from incomplete precipitation.  It separated as a compact 
gum which was rather difficult to manipulate. 
TABLE  IV 
Analysis of Type I  Meningococcus  Antibody Preparations 
rPar  ~iPo  a"  Volume serum 
No.  taken 
cc. 
7  200 No. 3 
+ 
250 No. 4 
8  400 No. 3 
9  200 No. 5 
10  50 No. 3t 
+ 
50 No. 7 
11  45 pooled 
~los. 1 to 8:~ 
Anti- 
Volume  total N  body N 
per cc.  Yield  Purifi-  anti-  of  anti-  per cc.  Yield  of  anti- total N  anti-  cation 
body  body  body  body  N  factor* 
solution  ~olution solution 
co.  rag.  rag.  per  cent  ~er ce~ 
64  5.12  0.880  5.9  79  13.5 
52  6.45  0.762  7.8  73  9.5 
52  3.59  0.600  8.6  89  I0.3 
58.5  2.08  0.163  10.6  80  7.5 
Remarks 
Filtered  through 
Seitz EK 
c~  ¢c 
Tricresolized  serum 
Not filtered 
33  1.34  0.144  8.7  91  10.4  "  " 
* Antibody nitrogen yield divided by total nitrogen yield. 
t Had been stored 6  months.  Antibody N  content  had fallen to  0.118  rag. 
per cc. 
Contained 11.24 rag. total N per cc. and 0.116 mg. antibody N per cc. 
The solution of the dialysis precipitate was  diluted with  1/10  its volume of 
M/1 phosphate buffer, pH 7.2, in order to increase the salt content to normal and 
to neutralize the solution.  This solution was then used to dissolve the fraction 
precipitated by carbon dioxide.  The final solution of the product was usually 
clear, colorless, and only slightly opalescent.  On standing at 0  to 4°C., a  small 
amount  of  precipitate  formed  slowly.  This  process  has  been  accelerated by 
incubating the antibody solution for several hours at 37°C. and then allowing it to 
stand  in  the  refrigerator for several days, after which  the  precipitate may be 
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The antibody solutions have been analyzed for total Kjeldahl nitro- 
gen and for antibody nitrogen according to  the  technique outlined. 
The analyses (Table IV) show that a 90 per cent yield of antibody was 
obtainable, while the corresponding purification with respect to total 
nitrogen averaged at least tenfold.  The relatively low yields in prepa- 
rations 7 and 8 are undoubtedly due to adsorption taking place during 
filtration  through  a  Seitz  filter.  Since  the  purification  factors  re- 
mained relatively unchanged, it is probable that both specific and non- 
specific proteins were alike lost.  In preparation 10, the serum, after 
the treatment with carbon dioxide, was left in the refrigerator for 24 
hours.  The precipitate collected on the walls of the flask, permitting 
TABLE  V 
Name or 
number 
Type I 
seruIn 
C. 
W.  0 
505  ++ 
506  -bOb 
F. 
504  0 
498  0 
500  0 
I  0 
Type I  serum 
concentrated 
++ 
+++ 
+++ 
-4- 
-4- 
.4_ 
::F 
-4- 
Type II 
serum 
0 
0 
:F 
0 
-4- 
+ 
"4- 
:t: 
0 
Type n 
serum con- 
centrated 
4- 
+ 
++ 
+ 
+ 
± 
Agglutination 
I-III 
I-III 
I-III 
I-III 
II 
II 
II* 
II* 
Pneumo- 
coccus 10 
Notes 
Before  intra- 
thecal serum 
After intrathecal 
serum 
II*  =  atypical Type II strain  (15). 
decantation of the clear supernatant, which was subsequently found 
to contain no antibody.  It is obvious from the low purification factor 
(7.5)  that  a  considerable amount of inactive protein  separated out 
during this treatment.  The low yield was found to be due to the use 
of too large a  proportion of distilled water in the purification of the 
dialysis precipitate.  In preparation  11,  the fraction precipitated by 
carbon dioxide was centrifuged off immediately after it formed and 
the supernatant was placed in the refrigerator for 48 hours.  A further 
precipitate  formed which upon  analysis was  found to  contain  only 
0.15  rag. or 3 per cent of the original antibody nitrogen and 9.74 mg. 
or 2 per cent of the original total nitrogen.  In other words, the anti- HENRY  W.  SCHERP  AND  GEOFFREY  RAKE  557 
body purification obtained in  this  additional  fraction  was  so  slight 
in comparison with that obtained in the main fractions, that it was not 
considered worth while to collect it.  The optimum procedure, there- 
fore, is to collect the fraction precipitated by carbon dioxide at room 
temperature as soon as it is formed. 
It had been hoped that sera concentrated in this manner could be 
used in the precipitin test with specimens of spinal fluid from cases of 
cerebrospinal meningitis sent into the laboratory to be typed.  Such 
sera might be of especial value in the case of those spinal fluids whose 
content of precipitinogen was too low to react with the unconcentrated 
sera.  However, even when trouble caused by the cloudiness of early 
preparations of the concentrated sera had been overcome, the results 
were confused by the occurrence of heterologous reactions.  This is 
brought out by the data summarized in Table V, which also illustrates 
the degree of reaction to  be expected in  testing spinal fluids.  The 
reactions with the concentrated sera were stronger throughout, and 
despite the  cross-reactions observed,  a  correct diagnosis  could have 
been made in all cases.  It is probable  that preliminary absorption 
of the sera with the group-specific antigen of the meningococcus  would 
eliminate these troublesome cross-reactions. 
DISCUSSION 
The quantitative determination of precipitins is the most accurate 
method available for the standardization of sera.  Whether the type- 
specific precipitin content of an antimeningococcal serum is an indica- 
tion of its therapeutic value has yet to be studied by protection tests 
in experimental meningococcus infection in mice (16) and in  possible 
clinical applications to man.  For the present, it can be said that of 
the  components thus  far identified in  the antigenic complex of the 
meningococcus, the  type-specific substance  elicits  the most prompt 
and the greatest antibody response (9, 17), at least when the vaccines 
used have been made from freshly isolated strains of the organism. 
Contrary to what might have been expected, the agglutination titre 
has not run parallel to the type-specific precipitin content of the sera 
nor to the precipitin titre of the sera with respect to the group-specific 
polysaccharide and protein of the meningococcus.  Whether this fact 
is due to partial degradation of the haptenes as isolated, or indicates 
the existence of haptenes as yet unidentified, cannot be said.  It must 558  MENINGOCOCCUS  INFECTION.  IX 
be borne in mind that  the data presented  represent  the antibody re- 
sponse of a single horse and so are not subject to broad generalization. 
The use of carbon dioxide as a precipitating agent in the purification 
and  concentration  of  antibodies  seems  to  offer  certain  advantages. 
All  operations  may  be  conducted  at  room  temperature  (20-25°C.). 
The precipitation  is rapid,  nearly quantitative,  and not critical  as to 
optimum conditions.  There is no problem concerning removal of the 
precipitating  agent, as is the case when salting-out methods are used. 
Type II antimeningococcal  horse sera have been concentrated  by the 
method outlined and it is not unlikely that the latter may find applica- 
tion in the purification of other types of antibody. 
SUMMARY 
Type I antimeningococcal  horse sera have been standardized by the 
quantitative determination of their type-specific precipitin content. 
By a method involving dialysis and precipitation by treatment with 
carbon dioxide, the antibody in such sera has been purified tenfold 
with respect to the nitrogen content. 
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